GeneDx

Empowering healthier lives through genetic testing & genomics 💙
Experts in exome & genome sequencing 🧬

[GeneDx @GeneDx]

Being recognized by @FastCompany’s Most Innovative Companies proves that pushing boundaries and always innovating is the path towards making sure people receive the care they need to live their fullest life.

[GeneDx @GeneDx]

We’re encouraged to see @GeneticCouns, @GeneticsSociety, and @TheACMG release a joint statement on autism and genetics. At GeneDx, we’re proud to support continued progress in genomic insights for patients and families.

Learn more: https://t.co/3d80Gnrr6H
#Autism #Genetics

[GeneDx @GeneDx]

Don't miss out! Register now to learn how integrated genomic and claims data can support precision clinical trials, natural history modeling, biomarker discovery, and evidence generation at scale.
➡️ Thursday, June 4 at 1 PM EDT | 10 AM PDT
https://t.co/rB1QKj7n1H

[Daniel S. Levine @dslevine]

John Wollman @KomodoHealth discusses how the company and @GeneDx are leveraging longitudinal patient data with genomic and phenotypic data to shorten rare disease diagnostic odysseys, accelerate natural hist studies, and enable better clinical decisions.
https://t.co/Lu91t2Hmbw

[chadi nabhan MD, MBA, FACP @chadinabhan]

Another clip from this week's #HealthcareUnfiltered podcast with @GeneDx President and CEO, Katherine Stueland who describes how the focus on rare diseases using genomics will help patients world-wide. An inspiring interview streaming everywhere.

https://t.co/Jow49PI00a

[GeneDx @GeneDx]

Must listen! An insightful conversation with Katherine Stueland and Fierce Healthcare's Anastassia Gliadkovskaya. 🎧

[GeneDx @GeneDx]

What does leadership look like in healthcare today?

Our CEO Katherine Stueland shares her perspective on #HealthcareUnfiltered.

Episode out tomorrow. 🎧

[chadi nabhan MD, MBA, FACP @chadinabhan]

Tom on #HealthcareUnfiltered, you're in for a treat as I host the President & CEO of @GeneDx Katherine Stueland who under her leadership, the company is making major strides in combatting "rare diseases' through genomics.
Wide range interview W many lessons learned. Pls tune in

[chadi nabhan MD, MBA, FACP @chadinabhan]

Tom on #HealthcareUnfiltered, you're in for a treat as I host the President & CEO of @GeneDx Katherine Stueland who under her leadership, the company is making major strides in combatting "rare diseases' through genomics.
Wide range interview W many lessons learned. Pls tune in

[Zevra Therapeutics @zevratx]

We’re proud to partner with @GeneDx to launch a Sponsored Genetic Testing Program for eligible patients in the U.S. with suspected Niemann-Pick disease type C (NPC).

Read the press release: https://t.co/oVBDXKS2fj

#RareDisease #NPC #GeneticTesting

[GeneDx @GeneDx]

Rare disease isn’t rare. It’s one of healthcare’s biggest blind spots.

In @FastCompany Impact Council, our CMO Linda Genen, MD, MPH shares why genomics can shorten years to days and bring clarity to care.

Read more → https://t.co/WwBHY0cKDU

[The Incubator Podcast @nicupodcast]

The countdown is officially on! In just 5 days, curious minds, bold ideas, and big neonatal questions collide at Delphi 2026 in Fort Lauderdale.✨🎤

If you're not able to join us in person, be sure to follow along on our social media; we will be sharing live updates throughout. 🙌

Huge thank you to our amazing exhibitors and sponsors. We couldn't have done this without your support:

→ @ChiesiGroup
→ @DrBrownsMedical
→ @GEHealthCare
→ @Pampers
→ @NSUFlorida
→ @prolacta
→ @meadjohnson
→ @Nicklaus4Kids
→ @ONYBiotech
→ @CergenX
→ @neurobell_
→ @Nemours
→ @GeneDx
→ @VTOxfordNetwork
→ @AbbottNews
→ @LABORIEMEDICAL
→ @MarchofDimes
→ @visitlauderdale

#DelphiConference2026 #NeonatalInnovation

[Contemporary Pediatrics @ContempPEDS]

In this short video, Mimi C. Lee, MD, PhD, explains the mechanism of whole genome and exome testing, highlighting @GeneDx's ExomeDx test and GenomeDx tests.

Watch the full interview with Lee, and learn more about genetic testing: https://t.co/yuucpiJKzj

[Inside Precision Medicine @Inside_PM]

Katherine Stueland, CEO of @GeneDx, on using early genomics to end the diagnostic odyssey and bring answers to more families.

Apple: https://t.co/AWwOfgG8A5
Spotify: https://t.co/vjk9yrf9sZ
Acast:
https://t.co/454VcqhwBE

#Genomics #PrecisionMedicine #RareDisease #screening

[CheckRare @CheckRare]

Up to 50% of unexplained epilepsy cases have a genetic cause, yet many go undetected.

Dr. Isabella Herman of Boys Town National Research Hospital shares how genetic testing is transforming epilepsy care.

This #EpilepsyAwarenessMonth, we’re teaming with @GeneDx to highlight how genetic testing can uncover the root cause of seizures and help providers deliver more precise, personalized care.

[Fierce Life Sciences Events @LifeSciEvents]

👏 Thrilled to have @GeneDx join #FierceHealthPayerSummit 2025 as a Gold Partner! Dec 3–5 in Nashville — payers, providers & innovators unite to address prior authorization & health equity.
Details: https://t.co/XwKgclNqwR
#HealthPayer

[Towards Healthcare Research & Consulting @TowardsHealths]

@GeneDx is making waves at NSGC 2025! Showcasing breakthroughs in genomics & precision medicine.

Read Complete News at: https://t.co/BE2ktXyHBn #MedicalInnovation #GenomicsResearch

#Genomics #PrecisionMedicine #NSGC2025 #HealthcareInnovation

[OncoDaily @oncodaily]

Howard McLeod Started a New Position as Senior Vice President of Clinical Affairs at GeneDx
@mcleodhoward @GeneDx

https://t.co/8FwJnwjF2M

#Cancer #Medicine #Health #Oncology #OncoDaily #GeneDx #MedX #MedNews #MedEd

[Fabric Genomics @FabricGenomics]

Fabric Genomics and @GeneDx are enabling decentralized testing powered by centralized intelligence. Together, we harness the power of data to deliver actionable genomic insights. Visit us at #ASHG2025
https://t.co/tEnmf8hqIT
#WGS

[National Organization for Rare Disorders (NORD) @RareDiseases]

What’s next for #GeneTherapy and #CellTherapy?

#NORD + @ASGCTherapy co-hosted a #NORDSummit panel on promising, cutting-edge science—and the challenges of access, affordability and equity. Featuring experts from @UMassChan and @GeneDx.

Patient voices + FUNDING = New treatments

[Genetic Engineering & Biotechnology News @GENbio]

At ASHG, Illumina Pilots Products for Mapped Reads, Multiomics

The company shared pilot data about its Constellation tech and released 5-Base, a product for jointly analyzing genetic and epigenetic data
@illumina @GeneDx
#multiomics #DNAmethylation #ASHG
https://t.co/3uZWN9GQsz

[Illumina @illumina]

We’ve spent years pushing the limits of what short-read sequencing can do. Now, with our emerging constellation mapped read technology, we’re breaking new barriers and enabling the industry to uncover even deeper insights from the genome.

@GeneDx recently piloted constellation to evaluate its performance in the most challenging genomic regions. Early results illustrate its ability to rapidly identify hard-to-detect variants implicated in rare disease, like DMPK, SMN1, and mosaic aneuploidy.

Joe Devaney, Director of the Laboratory Innovation Team at GeneDx, said: “We’re continually looking to advance research and clinical genomics to drive the future of precision medicine and better health outcomes for all. The level of detail we can achieve with Constellation provides promising insight into some of the world’s most complex and difficult-to-diagnose diseases.”

Constellation delivers long-range genomic insights with a simplified, on-flow-cell library prep that removes manual steps — all within the workflows our customers know and trust.

📍GeneDx presented the results of their pilot today at #ASHG25. Read more here: https://t.co/P1B86PUwfb